Parsabiv™ (etelcalcetide), an IV formulation similar to the oral calcimimetic Sensipar® (cinicalset), was recently approved by the U.S. Food and Drug Administration to treat secondary … [Read more...]
Nephrology News Roundup
Here’s a roundup of nephrology news over the past few weeks. Click on the headlines to browse the articles. Or, if you’ve discovered other newsworthy items that may be of interest to our team or your … [Read more...]
